You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創機器人-B(02252.HK):圖邁®單臂腔鏡手術機器人成功完成首例單孔腹腔鏡手術
格隆匯 12-19 21:30

格隆匯12月19日丨微創機器人-B(02252.HK)公佈,公司與首都醫科大學附屬北京友誼醫院(“北京友誼醫院”)張忠濤教授團隊及相關單位自主研發的圖邁®單臂腔鏡手術機器人(“圖邁®單臂”)於近日由張忠濤教授團隊和蘭州大學第一醫院李汛教授團隊共同完成了單臂機器人單孔腹腔鏡膽囊切除術,這是圖邁®單臂完成的首例人體臨牀試驗(FIM)手術。

圖邁®單臂由公司和北京友誼醫院及相關單位合作研發,具有完全自主知識產權的獨特單臂結構,移動靈活,設置便捷。其蛇形設計器械可以在狹小空間內實現七個自由度,相較於多臂機器人更為精細。圖邁®單臂以單孔的方式完成腹腔鏡手術,相較傳統多孔手術具有傷口小、疼痛輕、術後美觀度高等臨牀價值。

圖邁®單臂首例臨牀手術的成功,標誌着公司在外科手術微創傷化道路上的又一重大突破。本次試驗是對公司底層技術體系、前沿創新能力的又一次檢驗,也是圖邁®腔鏡手術解決方案的進一步領域拓展。公司將繼續加強與臨牀專家緊密合作,深化前沿探索與技術創新,為醫生與患者提供更多能夠延長和重塑生命的機器人智能手術全解方案。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account